What is the most recent earnings date for CARA stock?
CARA THERAPEUTICS INC (CARA) last reported earnings on 3/3/2025.
CARA THERAPEUTICS INC (CARA) Earnings History & Surprises
NASDAQ:CARA • US1407552082
Current stock price
5.32 USD
-0.23 (-4.14%)
At close:
5.43 USD
+0.11 (+2.07%)
After Hours:
CARA Earnings overview
Past quarterly earnings results for CARA THERAPEUTICS INC (CARA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 12, 2025
- Period
- Q1 / 2025
- EPS Estimate
- -$0.20
- Revenue Estimate
- 1.224M
Last Reported
Most Recent- Release Date
- Mar 3, 2025
- Period
- Q4 / 2024
- EPS Reported
- EPS Surprise
- %
- Revenue Surprise
- -10.63%
Beat Rate
Last 8 Quarters 25%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2024 | -0.19 | - | 67.15% | 1.455M | 1.628M | -10.63% | -51.56% | |
| Q3 2024 | -2.76 | -3.02 | 8.59% | -430.77% | 2.556M | 1.649M | 55.00% | -47.47% |
| Q2 2024 | -4.44 | -3.35 | -32.39% | -665.52% | 991K | 1.197M | -17.21% | -85.71% |
| Q1 2024 | -6.72 | -4.87 | -37.94% | -1,271.43% | 2.135M | 1.724M | 23.84% | -65.37% |
| Q4 2023 | -0.59 | -0.42 | -40.40% | -5.36% | 3.004M | 9.61M | -68.74% | -8.97% |
| Q3 2023 | -0.52 | -0.53 | 1.96% | -20.93% | 4.866M | 10.15M | -52.06% | -54.94% |
| Q2 2023 | -0.58 | -0.55 | -5.63% | -625.00% | 6.933M | 6.693M | 3.59% | -69.86% |
| Q1 2023 | -0.49 | -0.53 | 7.87% | 5.77% | 6.165M | 5.082M | 21.31% | 28.44% |
| Q4 2022 | -0.56 | -0.33 | -71.57% | 11.11% | 3.3M | 16.576M | -80.09% | 312.50% |
| Q3 2022 | -0.43 | -0.43 | -0.72% | -2,050.00% | 10.8M | 10.027M | 7.71% | -46.80% |
| Q2 2022 | -0.08 | -0.26 | 69.04% | 86.89% | 23M | 21.121M | 8.90% | - |
| Q1 2022 | -0.52 | -0.55 | 5.01% | -10.64% | 4.8M | 3.227M | 48.74% | 152.63% |
| Q4 2021 | -0.63 | -0.53 | -19.77% | -139.62% | 800K | 1.487M | -46.20% | -99.29% |
| Q3 2021 | -0.02 | -0.40 | 95.04% | 94.29% | 20.3M | 11.431M | 77.59% | 118.28% |
| Q2 2021 | -0.61 | -0.54 | -12.23% | -12.96% | 2.645M | -100.00% | -100.00% | |
| Q1 2021 | -0.47 | -0.60 | 21.90% | 24.19% | 1.9M | 2.405M | -21.00% | -76.54% |
| Q4 2020 | 1.59 | 0.37 | 327.91% | - | 112.1M | 49.601M | 126.00% | - |
| Q3 2020 | -0.35 | -0.61 | 42.54% | - | 9.3M | 4.867M | 91.08% | - |
| Q2 2020 | -0.54 | -0.68 | 20.47% | - | 5.6M | 5.158M | 8.57% | - |
| Q1 2020 | -0.62 | -0.63 | 1.76% | - | 8.1M | 4.856M | 66.80% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
12.75%
Max Revenue beat (4)
55.00%
Min Revenue beat (4)
-17.21%
Analysis
CARA has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, CARA has beaten the revenue estimates by 12.8% on average.
Related analysis
CARA THERAPEUTICS INC / CARA Earnings FAQ
Did CARA stock beat earnings estimates in the most recent quarter?
CARA THERAPEUTICS INC (CARA) missed EPS estimates and missed revenue estimates in the most recent quarter.